News

NEWS

March 07, 2016 Zika Virus Guidance from FDA Notes Safety of Plasma Protein Products and the Availability of Octapharma’s Octaplas™ HOBOKEN, N.J.–(BUSINESS WIRE)–Global health concerns regarding the Zika virus (ZIKV), a flavivirus, have prompted the U.S. Food and Drug Administration (FDA) to issue guidance for blood donation collection, recommending that donors at risk for the virus defer donations for four weeks.